Velarion Records
Free. Unsubscribe any time.

Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals, Inc. filed 6 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 12 transactions and 154,623 shares. 6 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Terns Pharmaceuticals, Inc. 12

Adoption dates in Terns Pharmaceuticals, Inc. 2

Results prints in Terns Pharmaceuticals, Inc. 0

Trades before a print in Terns Pharmaceuticals, Inc. 0

Interval to Terns Pharmaceuticals, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Terns Pharmaceuticals, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 18, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.